Skip to main content

Table 3 Availability of insulin in Bengaluru’s private-sector retail pharmacies based on type, delivery device and company type

From: Challenges constraining availability and affordability of insulin in Bengaluru region (Karnataka, India): evidence from a mixed-methods study

a. Private-sector retail pharmacies [N = 30]

Insulin type and delivery device

Company Type

Indian

Non-Indian

Combined (Indian & Non-Indian)

Human insulin (overall)

73.3% (n = 22)

96.7% (n = 29)

96.7% (n = 29)

 Vial

  40 IU/ml

66.7% (n = 20)

96.7% (n = 29)

96.7% (n = 29)

  100 IU/ml

50.0% (n = 15)

43.3% (n = 13)

66.7% (n = 20)

 Cartridge

  40 IU/ml

0.0% (n = 0)

0.0% (n = 0)

0.0% (n = 0)

  100 IU/ml

0.0% (n = 0)

30.0% (n = 9)

30.0% (n = 9)

 Pen

  40 IU/ml

0.0% (n = 0)

0.0% (n = 0)

0.0% (n = 0)

  100 IU/ml

0.0% (n = 0)

36.6% (n = 11)

36.7% (n = 11)

Analogue insulin (overall)

26.7% (n = 8)

76.7% (n = 23)

80.0% (n = 24)

 Vial

  40 IU/ml

0.0% (n = 0)

0.0% (n = 0)

0.0% (n = 0)

  100 IU/ml

20.0% (n = 6)

0.0% (n = 0)

20.0% (n = 6)

 Cartridge

  40 IU/ml

0.0% (n = 0)

0.0% (n = 0)

0.0% (n = 0)

  100 IU/ml

10.0% (n = 3)

30.0% (n = 9)

33.3% (n = 10)

 Pen

  40 IU/ml

0.0% (n = 0)

0.0% (n = 0)

0.0% (n = 0)

  100 IU/ml

0.0% (n = 0)

73.3% (n = 22)

73.3% (n = 22)

b. Public-sector hospital pharmacies [N = 5]

Human insulin (overall)

80.0% (n = 4)

60.0% (n = 3)

80.0% (n = 4)

 Vial

  40 IU/ml

80.0% (n = 4)

60.0% (n = 3)

80.0% (n = 4)

  100 IU/ml

60.0% (n = 3)

20.0% (n = 1)

60.0% (n = 3)

 Cartridge

  100 IU/ml

0.0% (n = 0)

20.0% (n = 1)

20.0% (n = 1)

 Pen

  100 IU/ml

0.0% (n = 0)

20.0% (n = 1)

20.0% (n = 1)

Analogue insulin (overall)

40.0% (n = 2)

40.0% (n = 2)

60.0% (n = 3)

 Vial

  40 IU/ml

0.0% (n = 0)

0.0% (n = 0)

0.0% (n = 0)

  100 IU/ml

40.0% (n = 2)

0.0% (n = 0)

40.0% (n = 2)

 Cartridge

  100 IU/ml

0.0% (n = 0)

20.0% (n = 1)

20.0% (n = 1)

 Pen

  100 IU/ml

0.0% (n = 0)

40.0% (n = 2)

40.0% (n = 2)